Maple Grove, MN – November 7, 2022 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has extended its line of Haloperidol Tablets, USP and is now offering unit dose packaging in 1 mg, 5 ... Read More
Strategic Partnership with CorePharma Further Expands Company’s Portfolio
Maple Grove, MN – October 19, 2022 — Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has added two near-term generic products to its portfolio in an exclusive ... Read More
Recognized by NCPA for Professional Leadership and Commitment to Advancing Independent Pharmacy
Maple Grove, MN – October 17, 2022 – Upsher-Smith Laboratories, LLC (Upsher-Smith) is pleased to announce that Khanh-Long (Ken) Thai, PharmD, co-founder of 986 Degrees ... Read More
Adds New Pipeline Product to its Portfolio
Maple Grove, MN – September 12, 2022 — Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has expanded its ongoing partnership with Appco Pharma LLC (Appco) with the addition ... Read More
Maple Grove, MN – August 19, 2022 — Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has divested two inactive ANDAs in an exclusive agreement with a New York-based pharmaceutical company. According to the terms ... Read More
